Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'ABT-418' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 46 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Patt, JT; Spang, JE; Buck, A; Cristina, H; Arras, M; Schubiger, PA; Westera, G
      Synthesis and in vivo studies of the stereoisomers of N-[C-11]methyl-homoepibatidine

      NUCLEAR MEDICINE AND BIOLOGY
    2. Newhouse, PA; Potter, A; Kelton, M; Corwin, J
      Nicotinic treatment of Alzheimer's disease

      BIOLOGICAL PSYCHIATRY
    3. Patt, JT; Spang, JE; Westera, G; Schubiger, PA
      [C-11]N-methylhomoepibatidine: Radiolabelling and biodistribution studies in mice.

      JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS
    4. Daly, JW; Garraffo, HM; Spande, TF; Decker, MW; Sullivan, JP; Williams, M
      Alkaloids from frog skin: the discovery of epibatidine and the potential for developing novel non-opioid analgesics

      NATURAL PRODUCT REPORTS
    5. Sihver, W; Langstrom, B; Nordberg, A
      Ligands for in vivo imaging of nicotinic receptor subtypes in Alzheimer brain

      ACTA NEUROLOGICA SCANDINAVICA
    6. Lin, NH; Abreo, MA; Gunn, DE; Lebold, SA; Lee, EL; Wasicak, JT; Hettinger, AM; Daanen, JF; Garvey, DS; Campbell, JE; Sullivan, JP; Williams, M; Arneric, SP
      Structure-activity studies on a novel series of cholinergic channel activators based on a heteroaryl ether framework

      BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
    7. Levin, ED; Damaj, MI; Glassco, W; May, EL; Martin, BR
      Bridged nicotine, isonicotine, and norisonicotine effects on working memory performance of rats in the radial-arm maze

      DRUG DEVELOPMENT RESEARCH
    8. Thomas, C; Ohnmacht, U; Zahn, K; Mohr, K; Gmeiner, P
      Ex-chiral pool synthesis and pharmacological aspects of 3-pyrrolidinylisoxazoles

      PHARMAZIE
    9. Singh, S; Avor, KS; Pouw, B; Seale, TW; Basmadjian, GP
      Design and synthesis of isoxazole containing bioisosteres of epibatidine as potent nicotinic acetylcholine receptor agonists

      CHEMICAL & PHARMACEUTICAL BULLETIN
    10. Wilens, TE; Biederman, J; Spencer, TJ; Bostic, J; Prince, J; Monuteaux, MC; Soriano, J; Fine, C; Abrams, A; Rater, M; Polisner, D
      A pilot controlled clinical trial of ABT-418, a cholinergic agonist, in the treatment of adults with attention deficit hyperactivity disorder

      AMERICAN JOURNAL OF PSYCHIATRY
    11. McGaughy, J; Decker, MW; Sarter, M
      Enhancement of sustained attention performance by the nicotinic acetylcholine receptor agonist ABT-418 in intact but not basal forebrain-lesioned rats

      PSYCHOPHARMACOLOGY
    12. Potter, A; Corwin, J; Lang, J; Piasecki, M; Lenox, R; Newhouse, PA
      Acute effects of the selective cholinergic channel activator (nicotinic agonist) ABT-418 in Alzheimer's disease

      PSYCHOPHARMACOLOGY
    13. LIN NH; MEYER MD
      RECENT DEVELOPMENTS IN NEURONAL NICOTINIC ACETYLCHOLINE-RECEPTOR MODULATORS

      Expert opinion on therapeutic patents
    14. RASMUSSEN T; SWEDBERG MDB
      REINFORCING EFFECTS OF NICOTINIC COMPOUNDS - INTRAVENOUS SELF-ADMINISTRATION IN DRUG-NAIVE MICE

      Pharmacology, biochemistry and behavior
    15. DONNELLYROBERTS DL; PUTTFARCKEN PS; KUNTZWEILER TA; BRIGGS CA; ANDERSON DJ; CAMPBELL JE; PIATTONIKAPLAN M; MCKENNA DG; WASICAK JT; HOLLADAY MW; WILLIAMS M; ARNERIC SP
      ABT-594 [(R)-5-(2-AZETIDINYLMETHOXY)-2-CHLOROPYRIDINE] - A NOVEL, ORALLY EFFECTIVE ANALGESIC ACTING VIA NEURONAL NICOTINIC ACETYLCHOLINE-RECEPTORS - I - IN-VITRO CHARACTERIZATION

      The Journal of pharmacology and experimental therapeutics
    16. NANRI M; YAMAMOTO J; MIYAKE H; WATANABE H
      PROTECTIVE EFFECT OF GTS-21, A NOVEL NICOTINIC RECEPTOR AGONIST, ON DELAYED NEURONAL DEATH INDUCED BY ISCHEMIA IN GERBILS

      Japanese Journal of Pharmacology
    17. TANI Y; SAITO K; IMOTO M; OHNO T
      PHARMACOLOGICAL CHARACTERIZATION OF NICOTINIC RECEPTOR-MEDIATED ACETYLCHOLINE-RELEASE IN RAT-BRAIN - AN IN-VIVO MICRODIALYSIS STUDY

      European journal of pharmacology
    18. DECKER MW; BANNON AW; BUCKLEY MJ; KIM DJB; HOLLADAY MW; RYTHER KB; LIN NH; WASICAK JT; WILLIAMS M; ARNERIC SP
      ANTINOCICEPTIVE EFFECTS OF THE NOVEL NEURONAL NICOTINIC ACETYLCHOLINE-RECEPTOR AGONIST, ABT-594, IN MICE

      European journal of pharmacology
    19. PRENDERGAST MA; JACKSON WJ; TERRY AV; DECKER MW; ARNERIC SP; BUCCAFUSCO JJ
      CENTRAL NICOTINIC RECEPTOR AGONISTS ABT-418, ABT-089, AND (-)-NICOTINE REDUCE DISTRACTIBILITY IN ADULT MONKEYS

      Psychopharmacology
    20. ARNERIC SP; CAMPBELL JE; CARROLL S; DAANEN JF; HOLLADAY MW; JOHNSON P; LIN NH; MARSH KC; PETERSON B; QUI YH; ROBERTS EM; RODRIGUES AD; SULLIVAN JP; TRIVEDI J; WILLIAMS M
      ABT-089 [3-(2(S)-PYRROLIDINYLMETHOXY)-2-METHYLPYRIDINE] - AN ORALLY EFFECTIVE CHOLINERGIC CHANNEL MODULATOR WITH POTENTIAL ONCE-A-DAY DOSING AND CARDIOVASCULAR SAFETY

      Drug development research
    21. BRIONI JD; KIM DJB; ONEILL A; BRODIE MS; DECKER MW; ARNERIC SP
      ABT-089 [2-METHYL-3-(2-(S)-PYRROLIDINYLMETHOXY) PYRIDINE DIHYDROCHLORIDE] - DISCRIMINATIVE STIMULUS PROPERTIES AND ELECTROPHYSIOLOGICAL ACTIONS

      Drug development research
    22. VALETTE H; BOTTLAENDER M; DOLLE F; DOLCI L; SYROTA A; CROUZEL C
      AN ATTEMPT TO VISUALIZE BABOON BRAIN NICOTINIC RECEPTORS WITH N-[C-11]ABT-418 AND N-[C-11]METHYL-CYTISINE

      Nuclear medicine communications
    23. STEVENS KE; WEAR KD
      NORMALIZING EFFECTS OF NICOTINE AND A NOVEL NICOTINIC AGONIST ON HIPPOCAMPAL AUDITORY GATING IN 2 ANIMAL-MODELS

      Pharmacology, biochemistry and behavior
    24. BUNNELLE WH; SINGAM PR; NARAYANAN BA; BRADSHAW CW; LIOU JS
      AN EFFICIENT, SCALEABLE PROCEDURE FOR THE CONVERSION OF ESTERS TO ISOXAZOLES

      Synthesis
    25. LIN NH; GUNN DE; RYTHER KB; GARVEY DS; DONNELLYROBERTS DL; DECKER MW; BRIONI JD; BUCKLEY MJ; RODRIGUES AD; MARSH KG; ANDERSON DJ; BUCCAFUSCO JJ; PRENDERGAST MA; SULLIVAN JP; WILLIAMS M; ARNERIC SP; HOLLADAY MW
      STRUCTURE-ACTIVITY STUDIES ON 2-METHYL-3-(2(S)-PYRROLIDINYLMETHOXY)PYRIDINE (ABT-089) - AN ORALLY BIOAVAILABLE 3-PYRIDYL ETHER NICOTINIC ACETYLCHOLINE-RECEPTOR LIGAND WITH COGNITION-ENHANCING PROPERTIES

      Journal of medicinal chemistry
    26. BADIO B; GARRAFFO HM; PLUMMER CV; PADGETT WL; DALY JW
      SYNTHESIS AND NICOTINIC ACTIVITY OF EPIBOXIDINE - AN ISOXAZOLE ANALOGOF EPIBATIDINE

      European journal of pharmacology
    27. PAPKE RL; THINSCHMIDT JS; MOULTON BA; MEYER EM; POIRIER A
      ACTIVATION AND INHIBITION OF RAT NEURONAL NICOTINIC RECEPTORS BY ABT-418

      British Journal of Pharmacology
    28. MEYER EM; TAY ET; PAPKE RL; MEYERS C; HUANG GL; DEFIEBRE CM
      3-[2,4-DIMETHOXYBENZYLIDENE]ANABASEINE (DMXB) SELECTIVELY ACTIVATES RAT ALPHA-7 RECEPTORS AND IMPROVES MEMORY-RELATED BEHAVIORS IN A MECAMYLAMINE-SENSITIVE MANNER

      Brain research
    29. PRENDERGAST MA; TERRY AV; JACKSON WJ; MARSH KC; DECKER MW; ARNERIC SP; BUCCAFUSCO JJ
      IMPROVEMENT IN ACCURACY OF DELAYED RECALL IN AGED AND NON-AGED, MATURE MONKEYS AFTER INTRAMUSCULAR OR TRANSDERMAL ADMINISTRATION OF THE CNSNICOTINIC RECEPTOR AGONIST ABT-418

      Psychopharmacology
    30. TANI Y; SAITO K; TSUNEYOSHI A; IMOTO M; OHNO T
      NICOTINIC ACETYLCHOLINE-RECEPTOR (NACH-R) AGONIST-INDUCED CHANGES IN BRAIN MONOAMINE TURNOVER IN MICE

      Psychopharmacology
    31. GLENNON RA; DUKAT M
      NICOTINE RECEPTOR LIGANDS

      Medicinal chemistry research
    32. BRIONI JD; MORGAN SJ; ONEILL AB; SYKORA TM; POSTL SP; PAN JB; SULLIVAN JP; AMERIC SP
      IN-VIVO PROFILE OF NOVEL NICOTINIC LIGANDS WITH CNS SELECTIVITY

      Medicinal chemistry research
    33. ELLIOTT RL; KOPECKA H; GUNN DE; LIN NH; GARVEY DS; RYTHER KB; HOLLADAY MW; ANDERSON DJ; CAMPBELL JE; SULLIVAN JP; BUCKLEY MJ; GUNTHER KL; ONEILL AB; DECKER MW; ARNERIC SP
      2-(ARYLOXYMETHYL)AZACYCLIC ANALOGS AS NOVEL NICOTINIC ACETYLCHOLINE-RECEPTOR (NACHR) LIGANDS

      Bioorganic & medicinal chemistry letters
    34. WILKIE GI; HUTSON P; SULLIVAN JP; WONNACOTT S
      PHARMACOLOGICAL CHARACTERIZATION OF A NICOTINIC AUTORECEPTOR IN RAT HIPPOCAMPAL SYNAPTOSOMES

      Neurochemical research
    35. SURBER BW; ELLIOTT RL; KOPECKA H; THOMAS SB
      SYNTHESIS OF [C-14] ABT-418, A CHOLINERGIC CHANNEL ACTIVATOR LABELED AT 2 SITES ON THE ISOXAZOLE RING

      Journal of labelled compounds & radiopharmaceuticals
    36. DOLLE F; DOLCI L; VALETTE H; BOTTLAENDER M; FOURNIER D; FUSEAU C; VAUFREY F; CROUZEL C
      SYNTHESIS AND C-11 LABELING OF 2 SELECTIVE HIGH-AFFINITY NICOTINIC CHOLINERGIC AGONISTS FOR EVALUATION AS RADIOLIGANDS FOR PET STUDIES

      Journal of labelled compounds & radiopharmaceuticals
    37. BJUGSTAD KB; MAHNIR VM; KEM WR; SOCCI DJ; ARENDASH GW
      LONG-TERM TREATMENT WITH GTS-21 OR NICOTINE ENHANCES WATER MAZE PERFORMANCE IN AGED RATS WITHOUT AFFECTING THE DENSITY OF NICOTINIC RECEPTOR SUBTYPES IN NEOCORTEX

      Drug development research
    38. WILEY JL; JAMES JR; ROSECRANS JA
      DISCRIMINATIVE STIMULUS PROPERTIES OF NICOTINE - APPROACHES TO EVALUATING POTENTIAL NICOTINIC RECEPTOR AGONISTS AND ANTAGONISTS

      Drug development research
    39. RADEK RJ; BRIGGS CA; SULLIVAN JP; KANG CH; ARNERIC SP
      EFFECTS OF THE CHOLINERGIC CHANNEL ACTIVATOR ABT-418 ON CORTICAL EEG - COMPARISON WITH (-)-NICOTINE

      Drug development research
    40. BUISSON B; GOPALAKRISHNAN M; ARNERIC SP; SULLIVAN JP; BERTRAND D
      HUMAN ALPHA-4-BETA-2 NEURONAL NICOTINIC ACETYLCHOLINE-RECEPTOR IN HEK-293 CELLS - A PATCH-CLAMP STUDY

      The Journal of neuroscience
    41. LIPPIELLO PM; BENCHERIF M; GRAY JA; PETERS S; GRIGORYAN G; HODGES H; COLLINS AC
      RJR-2403 - A NICOTINIC AGONIST WITH CNS SELECTIVITY .2. IN-VIVO CHARACTERIZATION

      The Journal of pharmacology and experimental therapeutics
    42. WARPMAN U; NORDBERG A
      EPIBATIDINE AND ABT 418 REVEAL SELECTIVE LOSSES OF ALPHA-4-BETA-2 NICOTINIC RECEPTORS IN ALZHEIMER BRAINS

      NeuroReport
    43. ARNERIC SP; SULLIVAN JP; DECKER MW; BRIONI JD; BANNON AW; BRIGGS CA; DONNELLYROBERTS D; RADEK RJ; MARSH KC; KYNCL J; WILLIAMS M; BUCCAFUSCO JJ
      POTENTIAL TREATMENT OF ALZHEIMER-DISEASE USING CHOLINERGIC CHANNEL ACTIVATORS (CHCAS) WITH COGNITIVE ENHANCEMENT, ANXIOLYTIC-LIKE, AND CYTOPROTECTIVE PROPERTIES

      Alzheimer disease and associated disorders
    44. DAMAJ MI; CREASY KR; WELCH SP; ROSECRANS JA; ACETO MD; MARTIN BR
      COMPARATIVE PHARMACOLOGY OF NICOTINE AND ABT-418, A NEW NICOTINIC AGONIST

      Psychopharmacology
    45. BRIONI JD; KIM DJB; BRODIE MS; DECKER MW; ARNERIC SP
      ABT-418 - DISCRIMINATIVE STIMULUS PROPERTIES AND EFFECT ON VENTRAL TEGMENTAL CELL-ACTIVITY

      Psychopharmacology
    46. TURCHI J; HOLLEY LA; SARTER M
      EFFECTS OF NICOTINIC ACETYLCHOLINE-RECEPTOR LIGANDS ON BEHAVIORAL VIGILANCE IN RATS

      Psychopharmacology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 06/08/20 alle ore 18:49:12